根治性前列腺切除术后放疗对复发模式差异影响的PSMA PET/CT评估
该研究纳入162例根治性前列腺切除术后生化复发且影像学阳性、未用雄激素剥夺治疗的患者,比较术后放疗与否的复发模式。结果显示术后放疗者盆腔外复发和骨转移更多,但盆腔内复发更少;仅前列腺床放疗者盆腔淋巴结复发更多,而盆腔外和骨复发更少。
要点
- 术后放疗者盆腔外复发和骨转移比例更高,但盆腔内复发更少。
- 仅前列腺床放疗者盆腔淋巴结复发更多,但盆腔外和骨复发更少。
- 术后放疗改变生化复发患者的复发模式,需前瞻性研究指导决策。
核心结论
- 术后放疗改变根治性前列腺切除术后生化复发患者的复发模式。
研究设计与样本
- 回顾性分析162例根治性前列腺切除术后非转移性前列腺癌生化复发患者,均有至少一个影像学阳性病灶,未接受雄激素剥夺治疗。
主要发现
- 病灶分析中,术后放疗组腹主动脉旁及骶前淋巴结阳性率34.2%高于未放疗组12.3%(p=0.002),骨转移率25.7%高于8.8%(p=0.01),髂总动脉分叉远端淋巴结复发率35.2%低于57.9%(p=0.05)。
- 患者分析中,术后放疗组仅盆腔复发率52.4%低于未放疗组79%(p=0.002),盆腔外复发率41.9%高于15.8%(p=0.001)。
- 仅前列腺床放疗组仅盆腔淋巴结复发率54.2%高于前列腺床加盆腔淋巴结放疗组23.4%(p=0.002),盆腔外复发率31.3%低于53.2%(p=0.03),骨复发率16.7%低于36.2%(p=0.031)。
关键数值与推荐
- 术后放疗组与未放疗组髂总动脉分叉远端淋巴结复发率分别为35.2%和57.9%(p=0.05)。
- 术后放疗组与未放疗组腹主动脉旁及骶前淋巴结阳性率分别为34.2%和12.3%(p=0.002)。
- 术后放疗组与未放疗组骨转移率分别为25.7%和8.8%(p=0.01)。
- 术后放疗组与未放疗组仅盆腔复发率分别为52.4%和79%(p=0.002),盆腔外复发率分别为41.9%和15.8%(p=0.001)。
- 仅前列腺床放疗组与前列腺床加盆腔淋巴结放疗组仅盆腔淋巴结复发率分别为54.2%和23.4%(p=0.002),盆腔外复发率分别为31.3%和53.2%(p=0.03),骨复发率分别为16.7%和36.2%(p=0.031)。
临床怎么用
- 对于根治性前列腺切除术后生化复发患者,应结合既往放疗史评估复发模式。
- PSMA PET/CT可用于识别术后放疗后非典型复发部位,指导个体化影像和管理决策。
局限性
- 回顾性研究设计,样本量有限,需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the differential impact of postoperative radiotherapy (RT) on recurrence patterns in patients treated with radical prostatectomy (RP) using [68Ga]Ga-PSMAHBED-CC conjugate 11 positron emission tomography (PSMA 11-PET). METHODS: We assessed 162 consecutive patients who experienced biochemical recurrence (BCR) after RP for nonmetastatic prostate cancer (PC). All had at least one positive lesion on imaging. No patient was on androgen deprivation therapy (ADT). Patients were categorized into those who had received adjuvant/salvage RT ± ADT and those who did not (RP only). Lesion- and patient-based analyses were performed. The impact of the radiation field was assessed. RESULTS: Overall, 57 BCR patients underwent RP only, 105 received postoperative RT. Median PSA was 1.01 ng/ml (IQR 0.58-2). In the lesion-based analysis, compared to the RP only patients, those who had received postoperative RT, had less lymph node (LN) recurrences distal to the common iliac bifurcation (35.2 vs. 57.9%, p = 0.05), but were more likely to harbor positive LNs proximal to the iliac bifurcation and in the presacral (34.2 vs. 12.3%, p = 0.002) areas as well as bone metastases (25.7 vs. 8.8%, p = 0.01). In the patient-based analysis, the patients with postoperative RT after RP had less recurrence in the pelvis only (pelvic LNs and/or prostate bed) (52.4 vs. 79%, p = 0.002), but were more likely to harbor extrapelvic recurrence (41.9 vs. 15.8%, p = 0.001). Patients who received RT to the prostate bed only had more recurrence to the pelvic LN only (54.2% vs. 23.4%, p = 0.002), but less extrapelvic recurrence (31.3 vs. 53.2%, p = 0.03) and less bone recurrence (16.7 vs. 36.2%, p = 0.031) compared to those patients, who received RT to the prostate bed and pelvic nodes. CONCLUSIONS: Postoperative radiation treatment alters the recurrence pattern in BCR patients after RP. Further prospective studies are needed to establish a decision tree for optimal imaging/management according to previous treatments.
引用
- Grubmüller B, Jahrreiss V, Huebner N, et al. Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [68Ga]Ga-PSMA ligand PET/CT(MRI). Prostate Cancer Prostatic Dis. 2020. PMID: 32994534. doi:10.1038/s41391-020-00294-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。